Picardi, M. and Vincenzi, A. (2020) “Is it time to increase the liposomal doxorubicin dosage for frontline therapy in young adults and adults with classic Hodgkin lymphoma? Comment on: ‘Is it time to reduce the doxorubicin dosage in Hodgkin lymphoma therapy?’”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301044.